Purple Biotech Ltd (PPBT) — Net Asset Momentum

Latest YoY growth as of December 2024: -4.0%

Purple Biotech Ltd (PPBT) recorded a net asset momentum of -4.0% as of December 2024, with net assets of ILA32.91 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Purple Biotech Ltd (PPBT) liquidity interval to measure how many days the company can operate on defensive assets alone.

YoY Momentum

-4.0%
Year-over-year

Current Net Assets

ILA32.91 Million
ILA · December 2024

Years of Data

8
2017 – 2024

Country

Israel
TA

Purple Biotech Ltd Net Asset Momentum (2017–2024)

This chart tracks Purple Biotech Ltd's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -4.0%, with net assets of ILA32.91 Million ILA as of December 2024. Read Purple Biotech Ltd total liabilities for a breakdown of total debt and financial obligations.

Annual Net Asset History for Purple Biotech Ltd (2017–2024)

The table below shows the complete annual net asset history for Purple Biotech Ltd from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Purple Biotech Ltd market cap and net worth.

Year Net Assets (ILA) Total Assets Total Liabilities YoY Momentum
2024 ILA32.91 Million ILA37.04 Million ILA4.13 Million ▼ -4.0%
2023 ILA34.30 Million ILA44.30 Million ILA10.01 Million ▼ -27.2%
2022 ILA47.10 Million ILA54.62 Million ILA7.52 Million ▼ -27.7%
2021 ILA65.11 Million ILA70.20 Million ILA5.09 Million ▼ -18.4%
2020 ILA79.75 Million ILA83.80 Million ILA4.05 Million ▲ +634.4%
2019 ILA10.86 Million ILA14.72 Million ILA3.86 Million ▼ -1.3%
2018 ILA11.00 Million ILA14.72 Million ILA3.72 Million ▲ +28.1%
2017 ILA8.59 Million ILA14.18 Million ILA5.59 Million